SCHEMBL170374

SCHEMBL170374

Cn1cnc(C(=O)O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1051405 0.98 KDM4E (0.44)
Imidazole SCHEMBL25322075 0.83 ALDH1A1 (0.41)
SCHEMBL23161485 0.83 GSK3B (0.40)
SCHEMBL1614140 0.82
SCHEMBL19265734 0.80
SCHEMBL9726872 0.80
SCHEMBL285283 0.80
SCHEMBL1051399 0.80
Hydrochloric Acid SCHEMBL709418 0.78 KDM5A (0.38)
Hydrochloric Acid SCHEMBL8457838 0.78 KDM5A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1050 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118477556-B Preparation method of aluminum etching solution 合肥中聚和成电子材料有限公司 2024-11-22 CN claimed
CN-110167944-B Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors 联合疗法公司 2024-08-23 CN claimed
CN-118477556-A Preparation method of aluminum etching solution 合肥中聚和成电子材料有限公司 2024-08-13 CN claimed
CN-118027772-A Mildew-proof and dew-proof environment-friendly paint and preparation method thereof 河北于氏防水材料有限公司 2024-05-14 CN claimed
US-20230374566-A1 METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-11-23 US claimed
EP-4217364-A1 METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA The Regents of the University of California (US) 2023-08-02 EP claimed
CN-116265620-A Leveling agent, copper electroplating liquid medicine and blind hole copper plating method 广东硕成科技股份有限公司 2023-06-20 CN claimed
US-11668708-B2 Method for reducing measurement error in latex agglutination immunoassay SEKISUI MEDICAL CO., LTD. (JP) 2023-06-06 US claimed
WO-2022067036-A1 METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-03-31 WO claimed
CN-110643032-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2022-01-28 CN claimed
EP-1956908-A2 CERTAIN COMPOSITIONS AND METHODS OF TREATMENT Cytokinetics, Inc. (US) 2008-08-20 EP claimed
EP-1902025-A1 KINASE INHIBITORS Allergan, Inc. (US) 2008-03-26 EP claimed
EP-1869019-A1 BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS Pfizer Products Incorporated (US) 2007-12-26 EP claimed
WO-2007136703-A1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
US-20070191391-A1 Urotensin II receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-16 US claimed
WO-2007081995-A2 UROTENSIN II RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-19 WO claimed
WO-2007067752-A2 CERTAIN COMPOSITIONS AND METHODS OF TREATMENT CYTOKINETICS, INC. (US) 2007-06-14 WO claimed
US-20070032478-A1 Kinase Inhibitors ALLERGAN, INC. 2007-02-08 US claimed
WO-2007008895-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2007-01-18 WO claimed
WO-2006106425-A1 BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS PFIZER PRODUCTS INC. (US) 2006-10-12 WO claimed